CY1124193T1 - Μια συνθεση νανογαλακτωματος ελαιου-σε-υδωρ της κλομπετασολης - Google Patents
Μια συνθεση νανογαλακτωματος ελαιου-σε-υδωρ της κλομπετασοληςInfo
- Publication number
- CY1124193T1 CY1124193T1 CY20211100482T CY211100482T CY1124193T1 CY 1124193 T1 CY1124193 T1 CY 1124193T1 CY 20211100482 T CY20211100482 T CY 20211100482T CY 211100482 T CY211100482 T CY 211100482T CY 1124193 T1 CY1124193 T1 CY 1124193T1
- Authority
- CY
- Cyprus
- Prior art keywords
- oil
- weight ratio
- clombetasol
- nanoemulsion
- clobetasol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Colloid Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Σχετίζεται με μια σύνθεση νανογαλακτώματος ελαίου-σε-ύδωρ έχοντας μια συνεχή υδατική φάση και διασπαρμένα σταγονίδια ελαίου, όπου το νανογαλάκτωμα περιλαμβάνει: (α) κλομπετασόλη• (β) ένα ή περισσότερα συστατικά ελαίου• και (γ) ένα ή περισσότερα επιφανειοδραστικά• μαζί με ένα ή περισσότερα φαρμακευτικώς αποδεκτά έκδοχα ή ουσίες-φορείς όπου: η ωσμωτικότητα του νανογαλακτώματος περιλαμβάνεται από 100 mOsm/Kg έως 500 mOsm/Kg• το μέγεθος μέσου όρου σταγονιδίων που μετρείται από Δυναμική σκέδαση φωτός περιλαμβάνεται από 1 nm έως 500 nm• ο λόγος βαρών μεταξύ των συστατικών ελαίου και του αθροίσματος των συστατικών ελαίου και ενός ή περισσότερων επιφανειοδραστικών περιλαμβάνεται από 0.001 έως 0.5• ο λόγος βαρών μεταξύ του συστατικού ελαίου και της κλομπετασόλης περιλαμβάνεται από 1:1 έως 200:1• και ο λόγος βαρών μεταξύ του επιφανειοδραστικού και της κλομπετασόλης περιλαμβάνεται από 2:1 έως 200:1. Επίσης σχετίζεται με διεργασίες για την παρασκευή της, τη χρήση της ως ένα φάρμακο, και στην προφύλαξη και/ή φλεγμονωδών παθήσεων ή καταστάσεων.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382393 | 2017-06-23 | ||
| PCT/EP2018/051218 WO2018233878A1 (en) | 2017-06-23 | 2018-01-18 | OIL NANOEMULSION COMPOSITION IN CLOBETASOL WATER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124193T1 true CY1124193T1 (el) | 2022-05-27 |
Family
ID=59285129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100482T CY1124193T1 (el) | 2017-06-23 | 2021-06-02 | Μια συνθεση νανογαλακτωματος ελαιου-σε-υδωρ της κλομπετασολης |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US10857160B2 (el) |
| EP (1) | EP3641728B9 (el) |
| JP (1) | JP7065895B2 (el) |
| KR (1) | KR102571107B1 (el) |
| CN (1) | CN110944625B (el) |
| AU (1) | AU2018288256B2 (el) |
| CA (1) | CA3067657A1 (el) |
| CL (1) | CL2019003707A1 (el) |
| CO (1) | CO2020000026A2 (el) |
| CR (1) | CR20200024A (el) |
| CY (1) | CY1124193T1 (el) |
| DK (1) | DK3641728T3 (el) |
| DO (1) | DOP2019000307A (el) |
| EC (1) | ECSP19089679A (el) |
| ES (1) | ES2875851T3 (el) |
| HR (1) | HRP20210865T1 (el) |
| HU (1) | HUE055016T2 (el) |
| IL (1) | IL271474B (el) |
| LT (1) | LT3641728T (el) |
| MX (1) | MX2019015410A (el) |
| MY (1) | MY190953A (el) |
| PE (1) | PE20200736A1 (el) |
| PH (1) | PH12019550291A1 (el) |
| PL (1) | PL3641728T3 (el) |
| PT (1) | PT3641728T (el) |
| RU (1) | RU2759901C2 (el) |
| SA (1) | SA519410841B1 (el) |
| SG (1) | SG11201912393XA (el) |
| SI (1) | SI3641728T1 (el) |
| TW (1) | TWI768056B (el) |
| WO (1) | WO2018233878A1 (el) |
| ZA (1) | ZA202000128B (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024005726A1 (en) * | 2022-06-30 | 2024-01-04 | Ilko Ilac Sanayi Ve Ticaret A.S. | Storage stable topical composition comprising clobetasol |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
| US8449867B2 (en) * | 2004-08-31 | 2013-05-28 | Stiefel Research Australia Pty Ltd | Microemulsion and sub-micron emulsion process and compositions |
| ES2429040T5 (es) * | 2004-08-31 | 2017-06-13 | Stiefel Research Australia Pty Ltd | Método y composiciones de microemulsión y emulsión submicrónica |
| FR2889662B1 (fr) * | 2005-08-11 | 2011-01-14 | Galderma Res & Dev | Emulsion de type huile-dans-eau pour application topique en dermatologie |
| CN102026623B (zh) * | 2008-05-14 | 2013-08-14 | 奥德纳米有限公司 | 用于治疗耳部病症的控制释放皮质类固醇组合物和方法 |
| US20110045050A1 (en) * | 2009-08-24 | 2011-02-24 | Atrium Medical Corporation | Nanoemulsion formulations for direct delivery |
| MX2013004296A (es) * | 2010-10-21 | 2013-09-26 | Cadila Healthcare Ltd | Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis. |
| US9789123B2 (en) | 2010-10-21 | 2017-10-17 | Cadila Healthcare Limited | Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis |
| CN102283850B (zh) * | 2011-08-25 | 2013-04-10 | 西北农林科技大学 | 一种水包油型复方酮康唑纳米药物及其制备方法 |
| KR20170113568A (ko) * | 2015-02-06 | 2017-10-12 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 폴리머 안정화된 약학 제제용 수중 유 에멀전의 제조 |
| CA2976952A1 (en) | 2015-03-05 | 2016-09-09 | Allergan, Inc. | Self-emulsifying drug delivery system (sedds) for ophthalmic drug delivery |
| TWI773641B (zh) * | 2015-05-08 | 2022-08-11 | 日商活效製藥股份有限公司 | 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑 |
| WO2016205001A1 (en) * | 2015-06-18 | 2016-12-22 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
| WO2017037663A1 (en) * | 2015-09-02 | 2017-03-09 | Cadila Healthcare Limited | Topical compositions comprising corticosteroids |
-
2018
- 2018-01-18 AU AU2018288256A patent/AU2018288256B2/en active Active
- 2018-01-18 SI SI201830297T patent/SI3641728T1/sl unknown
- 2018-01-18 CA CA3067657A patent/CA3067657A1/en active Pending
- 2018-01-18 US US16/069,473 patent/US10857160B2/en active Active
- 2018-01-18 HU HUE18700437A patent/HUE055016T2/hu unknown
- 2018-01-18 IL IL271474A patent/IL271474B/en unknown
- 2018-01-18 KR KR1020207000389A patent/KR102571107B1/ko active IP Right Grant
- 2018-01-18 RU RU2019144015A patent/RU2759901C2/ru active
- 2018-01-18 PT PT187004379T patent/PT3641728T/pt unknown
- 2018-01-18 ES ES18700437T patent/ES2875851T3/es active Active
- 2018-01-18 EP EP18700437.9A patent/EP3641728B9/en active Active
- 2018-01-18 MX MX2019015410A patent/MX2019015410A/es unknown
- 2018-01-18 WO PCT/EP2018/051218 patent/WO2018233878A1/en active Application Filing
- 2018-01-18 PE PE2019002570A patent/PE20200736A1/es unknown
- 2018-01-18 CR CR20200024A patent/CR20200024A/es unknown
- 2018-01-18 LT LTEP18700437.9T patent/LT3641728T/lt unknown
- 2018-01-18 CN CN201880040366.8A patent/CN110944625B/zh active Active
- 2018-01-18 PL PL18700437T patent/PL3641728T3/pl unknown
- 2018-01-18 SG SG11201912393XA patent/SG11201912393XA/en unknown
- 2018-01-18 JP JP2019569782A patent/JP7065895B2/ja active Active
- 2018-01-18 MY MYPI2019007526A patent/MY190953A/en unknown
- 2018-01-18 DK DK18700437.9T patent/DK3641728T3/da active
- 2018-06-07 TW TW107119689A patent/TWI768056B/zh active
-
2019
- 2019-12-05 DO DO2019000307A patent/DOP2019000307A/es unknown
- 2019-12-16 PH PH12019550291A patent/PH12019550291A1/en unknown
- 2019-12-17 CL CL2019003707A patent/CL2019003707A1/es unknown
- 2019-12-18 SA SA519410841A patent/SA519410841B1/ar unknown
- 2019-12-18 EC ECSENADI201989679A patent/ECSP19089679A/es unknown
-
2020
- 2020-01-03 CO CONC2020/0000026A patent/CO2020000026A2/es unknown
- 2020-01-08 ZA ZA2020/00128A patent/ZA202000128B/en unknown
-
2021
- 2021-05-31 HR HRP20210865TT patent/HRP20210865T1/hr unknown
- 2021-06-02 CY CY20211100482T patent/CY1124193T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2018000297A (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo | |
| PE20191474A1 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cancer | |
| CO2018003424A2 (es) | Composición farmacéutica y formulación de inyección subcutánea que comprende micelas y curcuminoides para reducir la grasa localizada y método para preparar la misma” | |
| PE20180038A1 (es) | Composiciones farmaceuticas topicas | |
| AR081542A1 (es) | Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno | |
| BR112016018673A2 (pt) | Composições de sistemas de distribuição de nanoemulsão | |
| BR112018005533A2 (pt) | microemulsões de monoésteres de sacarose | |
| CL2018003178A1 (es) | Composición farmacéutica | |
| CY1124193T1 (el) | Μια συνθεση νανογαλακτωματος ελαιου-σε-υδωρ της κλομπετασολης | |
| AR079639A1 (es) | Composicion de pasta de dientes anti-erosiva | |
| BR112014028069A2 (pt) | composição farmacêutica oftálmica, processo para a preparação de uma composição farmacêutica oftálmica, uso de uma composição farmacêutica oftálmica, e, método para a prevenção ou tratamento de uma infecção fúngica | |
| CO2020005366A2 (es) | Composición plaguicida que contiene tidiazurón y ácido poliglutámico | |
| AR108368A1 (es) | Preparación y dispersión de formulaciones de emulsión estable | |
| CL2015002832A1 (es) | Formulación farmaceutica que comprende fosfatidilcolina para el tratamiento de colitus ulcerosa. | |
| CO2022004529A2 (es) | Composición de xantofila que comprende luteína y zeaxantina con biodisponibilidad mejorada | |
| BR112019025591A2 (pt) | Composição farmacêutica compreendendo conjugado de fármaco-anticorpo c-met e uso do mesmo | |
| CL2018000391A1 (es) | Combinaciones farmacéuticas y su uso | |
| AR102778A1 (es) | Composición farmacéutica, su preparación y sus usos | |
| EA201691628A1 (ru) | Состав для личной гигиены | |
| BR112018014354A2 (pt) | processo de fabricação de uma bolsa de infusão estável, pronta para uso para uma formulação sensível à oxidação | |
| CO2017004809A2 (es) | Composiciones de triptamidas | |
| AR094914A1 (es) | Composición tensioactiva codisolvente de fenol-etoxilato | |
| PE20180488A1 (es) | Composiciones farmaceuticas solidas para el tratamiento del vhc | |
| CL2019000471A1 (es) | Formas sólidas de un compuesto de dihidroxi ciclopentilo disustituido con alfa, omega y métodos para su preparación y uso. (divisional solicitud 201601448) | |
| AR112700A1 (es) | Composiciones, usos y métodos para el tratamiento de infertilidad y subfertilidad |